MPHOSPH9

Across TCGA pan-cancer cohorts, MPHOSPH9 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MPHOSPH9 data layer compared with 28 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MPHOSPH9 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated MPHOSPH9 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LSCC show a favorable association.

HNSC and LSCC are the cancer types where MPHOSPH9 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Quartile	All	0.851	0.423	.017	10	view →
LSCC	OS	Tertile	II,III,IV	0.942	0.713	.027	1	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MPHOSPH9–HNSC (DFS)

Open the HNSC breakdown →